Amalgamated Bank Janux Therapeutics, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,090 shares of JANX stock, worth $31,468. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,090
Previous 1,090
-0.0%
Holding current value
$31,468
Previous $25,000
4.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding JANX
# of Institutions
187Shares Held
56.7MCall Options Held
839KPut Options Held
622K-
Ra Capital Management, L.P. Boston, MA11.2MShares$323 Million5.65% of portfolio
-
Janus Henderson Group PLC London, X04.46MShares$129 Million0.05% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.92MShares$84.3 Million3.15% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$72.9 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$69.8 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.2B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...